Pharmaceutical News and Articles

FDA Approves Fabhalta (iptacopan) for the Treatment of Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Mind, Body Symptoms Can Precede MS Diagnosis for Years

Patients in the earliest stages of multiple sclerosis might develop certain symptoms that offer an early clue to the degenerative nerve disease, researchers rep

2018 to 2021 Saw Increase in Pregnancy-Linked Drug OD Mortality Ratios

From 2018 to 2021, pregnancy-associated overdose mortality ratios increased consistently for women aged 10 to 44 years, according to a study published online No

Ischemic Strokes Less Severe With Left Atrial Appendage Closure in A-Fib

For patients with atrial fibrillation, ischemic strokes (IS) are less often fatal or disabling with left atrial appendage closure (LAAC) prophylaxis than with d

Cardiovascular Benefits Seen With as Few as 2,600 Steps Daily

Cardiovascular disease (CVD) benefits can be seen from as few as about 2,600 steps per day, according to a review recently published in the Journal of the Ameri

Colorectal Screening Rates Do Not Differ by 10-Year Life Expectancy in Seniors

Personalized colorectal cancer (CRC) screening based on individual life expectancy may increase the value of CRC screening programs, according to a study publis

2010 to 2020 Saw Disparities in Surgeon Supply Widen in the United States

Disparities in surgeon supply between rural and urban counties and between socially vulnerable and other counties widened in the United States from 2010 to 2020

Brain Stimulation Can Improve Prospective Memory in Schizophrenia

For patients with schizophrenia, bilateral high-frequency repetitive transcranial magnetic stimulation (rTMS) can improve event-based prospective memory (EBPM),

Concordant Hypertension Observed in Heterosexual Couples

Within heterosexual couples, concordance of hypertension is seen consistently across four countries, according to a study published online Dec. 6 in the Journal

New Weight-Loss Drug Zepbound Is Now Available, Company Says

The newly approved weight-loss medication known as Zepbound is now available for patients to take, drug maker Eli Lilly announced Tuesday. Today opens another c